ЛИТЕРАТУРА К РАЗДЕЛУ II
Алексеева ГВ, Ботаев НА, Горошкова ВВ.
[Use of semax at a follow-up of patients with posthypoxic encephalopathy]
Анастез реаним 1999;1:40-43.
Козловская ММ, Середенин СБ, Козловский ИИ, Е.А.Вальдман, ЛА.Андреева, Мясоедов НФ.
Сравнительное изучение фрагментов тафтсина на показатели условной реакции пассивного избегания.Хим Фарм Журнал 2001;35(3):3-5.
Мясоедов НФ, Скворцова ВИ, Насонов ЕЛ, Журавлева ЕИ, Гривенников ИА, Арсеньева ЕЛ, Суханов ИИ.
Исследование механизмов нейропротективного действия семакса в острый период ишемического инсульта.
Журн неврол психиатр Корсак 1999;99(5):15-19.
Середенин CБ, Козловская ММ, Бледнов ИА, Козловский ИИ, Семенова ТП. и др.
[The anxiolytic action of an analog of the endogenous peptide tuftsin on inbred mice with different phenotypes of the emotional stress reaction].
Журн высш нерв деят Павл 1998;48(1):153-160.
Яковлева ЕИ, Кузенков ВС, Федоров ВН, Скворцова ВИ, Koшелев ВБ, Гусев ЕИ, Ашмарин ИП.
Исследование эффективности семакса при глобальной церебральной ишемии in vivo.
Бюлл эксп биол мед 1999;127(8):172-174.
Abbott CR, Kennedy AR, Wren AM, Rossi M, Murphy KG, Seal LJ, Todd JF, ea
Identification of hypothalamic nuclei involved in the orexigenic effect of melanin-concentrating hormone. Endocrinology. 2003;144(9):3943-3949.
Abdelmalek Z. et al.
Mitogenic and melanogenic stimulation of normal human melanocytes by melanotropic peptides. PNAS USA1995;92:1789.
Abramov AV, Kolesnik IuM.
[Morphofunctional characteristics of gastrin-releasing peptide synthesizing system of the hypothalamus in normal conditions and in experimental diabetes in rats]
Morfologiia. 2001;120(5):46-51.
Albrecht D, Broser M, Kruger H.
Excitatory action of angiotensins II and IV on hippocampal neuronal activity in urethane anesthetized rats. Regul Pept 1997;70(2-3):105-109.
Amouyel P, Richard F, Cottel D.
The deletion allele of the angiotensin I converting enzyme gene as a genetic susceptibility factor for cognitive impairment.
Neurosci Lett 1996;217:203-205.
Andoh T. et al.
Nociceptin gene expression in rat dorsal root ganglia induced by peripheral inflammation. Neuroreport 1997;8(12):2793-2796.
Agrawal AK., Gupta CM.
Tuftsin-bearing liposomes in treatment of macrophage-based infections. Adv Drug Deliv Rev 2000;41(2):135-146.
Arihara Z. et al.
Immunoreactive orexin-A in human plasma. Peptides 2001;22(1):139-142.
Arletti R. et al.
Aged rats are still responsive to the antidepressant and memory-improving effects of oxytocin/ Neuropeptides 1995;29(3):177-82.
Bari F. et al.
Influence of hypoxia/ ischemia on cerebro-vascular responses to oxytocin in piglets. J Vasc Res1997;34(4):312-320.
Bashkatova VG, Koshelev VB, Fadyukova OE, Alexeev AA, Vanin AF, Rayevsky KS, Ashmarin IP, Armstrong DM.
Novel synthetic analogue of ACTH 4-10 (Semax) but not glycine prevents the enhanced nitric oxide generation in cerebral cortex of rats with incomplete global ischemia.
Brain Res 2001;894(1):145-149.
Bastos R. et al.
Alpha-adrenergic agonists inhibit the dipsogenic effect of angiotensin II by their stimulation of atrial natriuretic peptide release/.
Brain Res 2001;895(1-2):80-88.
Benelli A. et al.
Polymodal dose-response curve for oxytocin in the social recognition test. Neuropeptides 1995; 28(4):251-255.
Benoit A, Vargas MA, DesGroseillers L, Boileau G.
Endothelin-converting enzyme-like 1 (ECEL1) is present both in the plasma membrane and in the endoplasmic reticulum.
Biochem J. 2004 Mar 1.
Benoit SC, Clegg DJ, Seeley RJ, Woods SC.
Insulin and leptin as adiposity signals. Recent Prog Horm Res. 2004;59:267-85.
Bhattacharya SK. et al.
Stress and water balance: the roles of ANP, AVP and isatin.
Indian J Exp Biol 1998; 36(12):1195-200.
Bielsky IF, Hu SB, Szegda KL, Westphal H, Young LJ.
Profound impairment in social recognition and reduction in anxiety-like behavior in vasopressin V1a receptor knockout mice.
Neuropsychopharmacology. 2004;29(3):483-493.
Blanco M, Gallego R, Garcia-Caballero T, Dieguez C, Beiras A.
Cellular localization of orexins in human anterior pituitary. Histochem Cell Biol. 2003;120(4):259-64.
Blevins JE, Eakin TJ, Murphy JA, Schwartz MW, Baskin DG.
Oxytocin innervation of caudal brainstem nuclei activated by cholecystokinin. Brain Res. 2003;993(1-2):30-41.
Bull PM, Ludwig M, Blackburn-Munro GJ, Delgado-Cohen H, Brown CH, Russell JA.
The role of nitric oxide in morphine dependence and withdrawal excitation of rat oxytocin neurons. Eur J Neurosci. 2003;18(9):2545-2551.
Braszko JJ, Kulakowska A, Winnicka MM, Karwowskapolecka W.
CGP 42112A abolishes facilitation of recognition caused by angiotensin II and angiotensin II(3-7) in rats. Acta Neurobiol Exp 1997; 57:227-234.
Buwalda B. et al.
Physiological and behavioral effects of chronic intracerebroventricular infusion of corticotropin-releasing factor in the rat.
Psychoneuroendocrinol 1997;22(5):297-309.
Cameron VA. et al.
C-type natriuretic peptide expression in olfactory regions of rat brain is modulated by acute water deprivation, salt loading and central angiotensin II.
Neuroendocrinol 2001;73(1):46-53.
Campbell BM, Morrison JL, Walker EL, Merchant KM.
Differential regulation of behavioral, genomic, and neuroendocrine responses by CRF infusions in rats. Pharmacol Biochem Behav. 2004;77(3):447-455.
Carr JA.
Beta-endorphin inhibition of endogenous norepinephrine release from the A2 noradrenergic nucleus in vitro: Role of m-opiate receptors and Na+ ion permeability.
Brain Res Bull 1997; 44(1):19-23.
Carter SJ, Richardson CM, Wakerley JB.
Excitatory effects of oxytocin and cholecystokinin on oxytocin neurones: differences between virgin, pregnant and lactating rats.
Neurosci Lett. 2003;351(1):13-16.
Catania A.
et al.The neuropeptide alpha-MSH has specific receptors on neutrophils and reduced chemotaxis in vitro. Peptides 1996;17(4):675-679;
Chabot JG, Juaneda C, Dumont Y, Fournier A, Quirion R.
Evidence for the differential distribution of at least two adrenomedullin receptor subtypes in the rat brain. Scientific World Journal. 2001;1(12 Suppl 1):38.
Chang L, Ren Y, Liu X, Li WG, Yang J, Geng B, Weintraub NL, Tang C. Protective effects of ghrelin on ischemia/reperfusion injury in the isolated rat heart. J Cardiovasc Pharmacol. 2004;43(2):165-70.
Chodobski A. et al.
The presence of arginine vasopressin and its mRNA in rat choroid plexus epithelium. Mol Brain Res 1997;48(1):67-72.
Chriguer J. et al.
Hypothalamic atrial natriuretic peptide and secretion of oxytocin. Brain Res 2001;889(1-2):239-242.
Ciccocioppo R, Economidou D, Fedeli A, Angeletti S, Weiss F, Heilig M, Massi M.
Attenuation of ethanol self-administration and of conditioned reinstatement of alcohol- seeking behaviour by the antiopioid peptide nociceptin/orphanin FQ in alcohol-preferring rats.
Psychopharmacology (Berl). 2004;172(2):170-178.
Crawley J.
Functional interactions of galanin and acetylcholin relevance to memory and Alzheimer disease. Behav. Brain Res. 1993; 57: 133.
Dauvilliers Y, Baumann CR, Carlander B, Bischof M, Blatter T, et al.
CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, and other hypersomnias and neurological conditions.
J Neurol Neurosurg Psychiatry. 2003;74(12):1667-73.
Deguchi K, Sasaki I, Touge T, Tsukaguchi M, Takeuchi H, Kuriyama S.
Abnormal baroreceptor-mediated vasopressin release as possible marker in early diagnosis of multiple system atrophy.
J Neurol Neurosurg Psychiatry. 2004;75(1):110-115.
Delalle I. et al.
Laminar distribution of neuropeptide Y immunoreactive neurons in human prefrontal cortex during development.
J Compar Neurology 1997;379 (4):515-522.
Dembinski A, Warzecha Z, Ceranowicz P, Tomaszewska R, Stachura J, Konturek SJ, Konturek PC.
Ghrelin attenuates the development of acute pancreatitis in rat. J Physiol Pharmacol. 2003;54(4):561-73.
Depner UB, Reinscheid RK, Takeshima H, Brune K, Zeilhofer HU.
Normal sensitivity to acute pain, but increased inflammatory hyperalgesia in mice lacking the nociceptin precursor polypeptide or the nociceptin receptor.
Eur J Neurosci. 2003;17(11):2381-2387.
Derad I, Pietrowsky R, Dodt C.
Enhanced psychophysiological signs of attention after ACE- inhibition by captopril. Psychophysiol 1996;33:295-301.
Desprat C. & Zajac JM.
Hypothermic effects of neuropeptide FF analogues in mice. Pharmacol Biochem Behav 1997;58(2):559-563
Diaz E, Silva M, Israel A.
Role of brain dopaminergic system in the adrenomedullin-induced diuresis and natriuresis. Pharmacol Res. 2003;48(5):489-96.
Drazen DL, Wortman MD, Schwartz MW, Clegg DJ, van Dijk G, Woods SC, Seeley RJ.
Adrenalectomy alters the sensitivity of the central nervous system melanocortin system. Diabetes. 2003;52(12):2928-2934.
Dumont Y. et al.
A selective CGRP(2) agonist, [Cys(Et)(2,7)]hCGRP - comparison in prototypical CGRP(1) and CGRP(2) in vitro bioassays.
Can J Physiol Pharmacol 1997;75(6):671-676.
Dunzendorfer S, Feistritzer C, Enrich B, Wiedermann CJ. Neuropeptide-induced inhibition of IL-16 release from eosinophils. Neuroimmunomodulation. 2002-2003;10(4):217-23.
Dupouy V. & Zajac JM.
Neuropeptide FF receptors control morphine-induced analgesia in the parafascicular nucleus and the dorsal raphe nucleus.
Eur J Pharmacol 1997;330(2-3):129-137
During MJ, Cao L, Zuzga DS, Francis JS, Fitzsimons HL, Jiao X, Bland RJ, et al.
Glucagon-like peptide-1 receptor is involved in learning and neuroprotection. Nat Med. 2003;9(9):1173-1179.
Duvauchelle et al.
DAMGO and DPDPE facilitation of brain stimulation reward thresholds is blocked by the dopamine antagonist cis-flupenthixol.
Neuropharmacology 1997; 36(8):1109-1114.
Dzaja A, Dalal MA, Himmerich H, Uhr M, Pollmacher T, Schuld A.
Sleep enhances nocturnal plasma ghrelin levels in healthy subjects. Am J Physiol Endocrinol Metab. 2004 Feb 10/Eikelis N, Lambert G, Wiesner G, et al.
Extra-adipocyte leptin release in human obesity and its relation to sympathoadrenal function. Am J Physiol Endocrinol Metab. 2004 Jan 13/.
Ellacott KL, Cone RD.
The Central Melanocortin System and the Integration of Short- and Long-term Regulators of Energy Homeostasis.
Recent Prog Horm Res. 2004;59:395-408.
Elshourbagy NA et al.
Receptor for the pain modulatory neuropeptide FF and AF is orphan protein-couled receptor. J Biol Chem 2000;275:25965.
Engelmann M, Bull PM, Brown CH, Landgraf R, Horn TF, Singewald N, Ludwig M,Wotjak CT. GABA selectively controls the secretory activity of oxytocin neurons in the rat supraoptic nucleus. Eur J Neurosci. 2004;19(3):601-608.
Farrokhi C, Blanchard DC, Griebel G, Yang M, Gonzales C, Markham C, Blanchard RJ.
Effects of the CRF1 antagonist SSR125543A on aggressive behaviors in hamsters. Pharmacol Biochem Behav. 2004;77(3):465-469.
Fekete E, Vigh J, Bagi EE, Lenard L.
Gastrin-releasing peptide microinjected into the amygdala inhibits feeding. Brain Res. 2002;955(1-2):55-63.
Fermepin N. et al.
B- type and C-type natriuretic peptides modify norepineph-rine uptake in discrete encephalic nuclei of the rat.
Cell Mol Neurobiol 2000;20(6):763-771.
Fernandez F, Misilmeri MA, Felger JC, Devine DP.
Nociceptin/orphanin FQ increases anxiety-related behavior and circulating levels of corticosterone during neophobic tests of anxiety.
Neuropsychopharmacology. 2004;29(1):59-71.
Franchini LF, Rubinstein M, Vivas L.
Reduced sodium appetite and increased oxytocin gene expression in mutant mice lacking beta- endorphin.
Neuroscience. 2003;121(4):875-81.
Fuxe K. et al.
NPY Y1 receptor-like immunoreactivity exists in a subpopulation of beta-endorphin immunoreactivie nerve cells in the acrurate nucleus.
Neurosci Lett 1997; 225(1): 49-52.
Garrido MM, Fuentes JA, Manzanares J.
Gastrin-releasing peptide mediated regulation of 5-HT neuronal activity in the hypothalamic paraventricular nucleus under basal and restraint stress conditions.
Life Sci. 2002;70(25):2953-66.
Gilman CP, Perry T, Furukawa K, Grieg NH, Egan JM, Mattson MP.
Glucagon-like peptide 1 modulates calcium responses to glutamate and membrane depolarization in hippocampal neurons.
J Neurochem. 2003;87(5):1137-1144.
Govantes C, Marin J.
Effect of angiotensin converting enzyme inhibi-tors on quality of life in hypertensive patients. Pharmacodynamic basis. Fundam Clin Pharmacol 1996;10:400-405.
Gozes I. et al.
Learning and sexual deficiencies in transgenic mice carrying a chimeric vasoactive intestinal peptide gene J Mol Neurosci 1993;4(3):185-193.
Harvey J.
Leptin: a multifaceted hormone in the central nervous system. Mol Neurobiol. 2003;28(3):245-58.
Hegarty A. & Felder R.
Vasopressin and V-1-receptor antagonists modulate the activity of solitary tract nucleus neurons receiving baroreceptor input.
Amer J Physiol Regul Integr C, 1997; 42(1):R143-R152.
Heinrichs S. et al.
Corticotropin-releasing factor CRF1, but not CRF2, receptors mediate anxiogenic -like behavior. Regul Pept 1997;71(1):15-21.
Henderson G. & Mcknight AT.
The orphan opioid receptor and its endoge-nous ligand nociceptin/ orphanin FQ. Review Trends Pharmac Sci 1997;18(8): 293-300.
Holmes PV et al.
Chronic social stress increases levels of preprogalanin mPNA in the rat locus coerules. Pharmacol.Biochem. Behav. 1995; 50: 655.
Hosoda H, Kojima M, Kangawa K.
Ghrelin and the regulation of food intake and energy balance. Mol Intervent. 2002;2(8):494-503.
Horvath TL et al.
Galanin neurons exhibit estrogen receptor immunoreactivity in the female rat mediobasal hypothalamus. Brain Res. 1995; 675: 321.
Huang WH. & Hanson GR.
Differential effect of haloperidol on release of neurotensin in extrapyramidal and limbic systems. Eur J Pharmacol 1997;332 (1):15-21.
Hughes PM, Anthony DC, Ruddin M, Botham MS, et al.
Focal lesions in the rat central nervous system induced by endothelin-1. J Neuropathol Exp Neurol. 2003;62(12):1276-1286.
Huitinga I, Erkut ZA, van Beurden D, Swaab DF.
Impaired hypothalamus-pituitary-adrenal axis activity and more severe multiple sclerosis with hypothalamic lesions.
Ann Neurol. 2004;55(1):37-45.
Ishii S, Kamegai J, Tamura H, Shimizu T, Sugihara H, Oikawa S.
Hypothalamic neuropeptide Y/Y1 receptor pathway activated by a reduction in circulating leptin, but not by an increase in circulating ghrelin, contributes to hyperphagia associated with triiodothyronine-induced thyrotoxicosis.
Neuroendocrinology. 2003;78(6):321-30.
Jenkins TA, Chai SY, Mendelsohn FAO.
Effect of angiotensin II on striatal dopamine release in the spontaneous hypertensive rat. Clin Exp Hypertension 1997;19(5-6):645-658.
Jones D. et al.
Effects of centrally administred orexin-1 and orexin A: a role for orexin-1 receptors in orexin-B- induced hyperactivity.
Psychopharmacol 2001;153(2):210-218.
Josselyn SA. et al.
Evidence for CCKA receptor involvement in the acquisition of conditioned activity produced by cocaine Brain Res 1997;763(1):93-102.
Juaneda C, Dumont Y, Chabot JG, Fournier A, Quirion R. Adrenomedullin receptor binding sites in rat brain and peripheral tissues. Eur J Pharmacol. 2003;474(2-3):165-74.
Kahler CM, Kaufmann G, Kahler ST, Wiedermann CJ.
The neuropeptide secretoneurin stimulates adhesion of human monocytes to arterial and venous endothelial cells in vitro.
Regul Pept. 2002;110(1):65-73.
Kakinuma Y, Hama H, Sugiyama F, Goto K, Murakami K, Fukamizu A.
Anti-apoptotic action of angiotensin fragments to neuronal cells from angiotensinogen knock-out mice. Neurosci Lett 1997;232(3): 167-170.
Kalra SP, Kalra PS.
Neuropeptide Y: a physiological orexigen modulated by the feedback action of ghrelin and leptin. Endocrine. 2003;22(1):49-56.
Kask K. et al.
Galanin receptors: involvement in feeding, pain, depression and Alzheimers disease. Life Sci. 1997;60(18):1523-1533.
Kastin AJ, Akerstrom V, Pan W.
Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier. J Mol Neurosci. 2002;18(1-2):7-14.
Kent P. et al.
Bombesin-induced HPA and sympathetic activation requires CRH receptors. Peptides 2001;22(1):57-65.
Kinzig KP, D'Alessio DA, Herman JP, Sakai RR, Vahl TP, Figueiredo HF, Murphy EK, Seeley RJ. CNS glucagon-like peptide-1 receptors mediate endocrine and anxiety responses to interoceptive and psychogenic stressors.
J Neurosci. 2002;22(23):10470-10476.
Kinzig KP, D'Alessio DA, Seeley RJ.
The diverse roles of specific GLP-1 receptors in the control of food intake and the response to visceral illness.
J Neurosci. 2002;22(23):10470-10476.
Kirchmair R, Gander R, Egger M, Hanley A, Silver M, et al.
The neuropeptide secretoneurin acts as a direct angiogenic cytokine in vitro and in vivo. Circulation. 2004;109(6):777-83.
Kis B, Abraham CS, Deli MA, Kobayashi H, Niwa M, Yamashita H, Busija DW, Ueta Y.
Adrenomedullin, an autocrine mediator of blood-brain barrier function. Hypertens Res. 2003;26 Suppl:S61-70.
Kleeberg J, Petzold GC, Major S, Dirnagl U, Dreier JP.
Endothelin-1 induces cortical spreading depression via activation of the ETA receptor/phospholipase C pathway in vivo.
Am J Physiol Heart Circ Physiol. 2003 Dec 4.
Knigge U, Kjaer A, Kristoffersen U, Madsen K, Toftegaard C, Jorgensen H, Warberg J. Histamine and prostaglandin interaction in regulation of oxytocin and vasopressin secretion. J Neuroendocrinol. 2003;15(10):940-945.
Koch G. et al.
Opioid activities of human beta-casomorphins. Naun Schmied Arch Pharm 1985;331:351-354.
Kotani M. et al.
Functional characterisation of a human receptor for neuro-peptide FF and related peptides. Brit J Pharmacol 2001;133(1):138-144.
Koyama Y, Tsujikawa K, Matsuda T, Baba A.
Intracerebroventricular administration of an endothelin ETB receptor agonist increases expressions of GDNF and BDNF in rat brain.
Eur J Neurosci. 2003;18(4):887-94.
Kulkosky P. et al.
Bombesin reduces alcohol choice in nutritive expectancy and limited-access procedures. Alcohol 1992;9(2):123-127.
Larm JA, Gundlach AL.
Galanin-life peptide (GALP) mRNA expression is restricted to arcuate nucleus of hypothalamus in adult male rat brain.
Neuroendocrinol 2000;72,S22-24/25;67.
Laslop A, Becker A, Lindberg I, Fischer-Colbrie R.
Proteolytic processing of chromogranins is modified in brains of transgenic mice. Ann N Y Acad Sci. 2002;971:49-52.
Lechner T, Adlassnig C, Humpel C, Kaufmann WA, Maier H, еа.
Chromogranin peptides in Alzheimer's disease. Exp Gerontol. 2004;39(1):101-113.
Lin Y, Matsumura K, Fukuhara M, Kagiyama S, Fujii K, Iida M.
Ghrelin Acts at the Nucleus of the Solitary Tract to Decrease Arterial Pressure in Rats. Hypertension. 2004 Mar 1/
Lincoln G. & Baker B.
Seasonal and photoperioid-induced changes in the secretion of α-melanocyte-stimulating hormone: Temporal relationship with changes in beta-endorphin, prolactin, follicle-stimulating hormone, activity of gonads.
J Endocrinol 1995;144:471.
Lipton J. et al.
Peptide modulation of inflammatory process within the brain. Neuroimmunomodul 1998;5(3-4):178-183.
Lovshin JA, Huang Q, Seaberg R, Brubaker PL, Drucker DJ.
Extrahypothalamic expression of the Glucagon-like Peptide-2 (GLP-2) receptor is coupled to reduction of glutamate-induced cell death in cultured hippocampal cells.
Endocrinology. 2004 Apr 1/.
Lu XY, Barsh GS, Akil H, Watson SJ.
Interaction between alpha-melanocyte-stimulating hormone and corticotropin-releasing hormone in the regulation of feeding and hypothalamo-pituitary-adrenal responses.
J Neurosci. 2003;23(21):7863-7872.
Lublin A. et al.
Isolation and characterization of the gene enco-ding the type 5 mouse (Mus musculus) somatostatin receptor (msst(5)).
Gene 1997;195(1):63-66.
Lutz TA. et al.
Evidence for a physiological role of central calcitonin gene-related peptide (CGRP) receptors in the control of food intake in rats.
Neurosci Lett 1997;230(3):159-162.
MacMillan et al.
Atrial natriuretic factor: does it have a role in psychiatry? Biol Psychiatry 1994; 35:272
Makman MH. et al.
Presence and characterization of nociceptin (orphanin FQ) receptor binding in adult rat and human fetal hypothalamus.
Brain Res 1997;762 (1-2):247-250.
Mamiya T, Yamada K, Miyamoto Y, Konig N, Watanabe Y, Noda Y, Nabeshima T.
Neuronal mechanism of nociceptin-induced modulation of learning and memory: involvement of N-methyl- D-aspartate receptors.
Mol Psychiatry. 2003;8(8):752-65.
Mantella RC, Rinaman L, Vollmer RR, Amico JA.
Cholecystokinin and D-fenfluramine inhibit food intake in oxytocin-deficient mice. Am J Physiol Regul Integr Comp Physiol. 2003;285(5):R1037-1045.
Marksteiner J, Kaufmann WA, Gurka P, Humpel C.
Synaptic proteins in Alzheimer's disease. J Mol Neurosci. 2002;18(1-2):53-63.
Martinez V, Tache Y.
Bombesin and the brain-gut axis. Peptides 2000; 21(11):1617-1625.
Mathis JP. et al.
Carboxyl terminal peptides derived from pre-pro-orphanin FQ/nococeptin are produced in hypothalamus and possess analgesic bioactivities.
Brain Res 2001;895:89-94.
Miller MA et al.
Preservation of noradrenergic neurons in the locus ceruleus that coexpress galanin mRNA in Alzheimer disese.
J Neurochem 1999;73:2028-2036.
Moller C, Sommer W, Thorsell A, Rimondini R, Heilig M.
Anxiogenic-like action of centrally administered glucagon-like peptide-1 in a punished drinking test. Prog Neuropsychopharmacol Biol Psychiatry. 2002;26(1):119-122.
Mongeau R. & Marsden CA.
Effect of central and peripheral administrations of chole-cystokinin-tetrapeptide on panic-like reactions induced by stimulation of the dorsal periaqueductal grey area in the rat.
Biol Psychiatry 1997; 42(5):335-344.
Moody TW, Merali Z.
Bombesin-like peptides and associated receptors within the brain: distribution and behavioral implications.
Peptides. 2004;25(3):511-520.
Mori Y. et al.
Effects of adrenomedullin on rat cerebral arterioles. Eur J Pharmacol 1997;330(2-3):195-198.
Namiki A, Kubota T, Fukazawa M, Ishikawa M, Moroi M, et al.
Endothelin-1 concentrations in pericardial fluid are more elevated in patients with ischemic heart disease than in patients with nonischemic heart disease.
Jpn Heart J. 2003;44(5):633-44.
Nie Z, Schweitzer P, Roberts AJ, Madamba SG, Moore SD, Siggins GR.
Ethanol augments GABAergic transmission in the central amygdala via CRF1 receptors. Science. 2004;303(5663):1512-154.
Nishikawa H, Hata T, Itoh E, Funakami Y.
A Role for Corticotropin-Releasing Factor in Repeated Cold Stress-Induced Anxiety-Like Behavior during Forced Swimming and Elevated Plus-Maze Tests in Mice.
Biol Pharm Bull. 2004;27(3):352-356.
O'Callaghan D, Gaine SP.
Bosentan: a novel agent for the treatment of pulmonary arterial hypertension. Int J Clin Pract. 2004;58(1):69-73.
Onaka T, Ikeda K, Yamashita T, Honda K.
Facilitative role of endogenous oxytocin in noradrenaline release in the rat supraoptic nucleus. Eur J Neurosci. 2003;18(11):3018-3026.
Osajima A, Okazaki M, Tamura M, Anai H, Kabashima N, et al.
Comparison of plasma levels of mature adrenomedullin and natriuretic peptide as markers of cardiac function in hemodialysis patients with coronary artery disease.
Nephron. 2002;92(4):832-9.
Osborn J, Camara A.
Renal neurogenic mediation of ICV angiotensin II hypertension in rats raised on high sodium chloride diet. Hypertension 1997;30(3 Part 1):331-336.
Pang L et al.
Membranecholesterol modulates galanin-GalR2 interaction. Boichemistry 1999;38:12003-12011.
Patel Y. et al.
Molecular pharmacology of somatostatin receptor subtypes. J Endocrin Invest 1997; 20(6):348-367.
Paul C, Peers SH, Woodhouse LE, Thornback JR, Goodbody AE, Bolton C.
The detection and quantitation of inflammation in the central nervous system during experimental allergic encephalomyelitis using the radiopharmaceutical 99mTc-RP128.
J Neurosci Meths 2000;98(1):83-90.
Pedersen EB. et al.
Pulsatile secretion of atrial natriuretic peptide and brain natriuretic peptide in healthy humans. Clin Sci (Col) 1999;97(2):201-206.
Perry T, Greig NH.
The glucagon-like peptides: a new genre in therapeutic targets for intervention in Alzheimer's disease. J Alzheimers Dis. 2002;4(6):487-496.
Perry T, Lahiri DK, Sambamurti K, Chen D, Mattson MP, et al.
Ups and downs for neuropeptides in body weight homeostasis: pharmacological potential of cocaine amphetamine regulated transcript and pre-proglucagon-derived peptides.
Eur J Pharmacol. 2002;440(2-3):159-172.
Perry T, Lahiri DK, Sambamurti K, Chen D, Mattson MP, Egan JM, Greig NH.
Glucagon-like peptide-1 decreases endogenous amyloid-beta peptide (Abeta) levels and protects hippocampal neurons from death induced by Abeta and iron.
J Neurosci Res. 2003;72(5):603-612.
Pohl M. et al.
Cholecystokinin (CCK)-like material and CCK mRNA levels in the rat brain and spinal cord after acute or repeated morphine treatment.
Neuropeptides 1992;21(3):193-200.
Porkka-Heiskanen T, Alanko L, Kalinchuk A, Heiskanen S, Stenberg D.
The effect of age on prepro-orexin gene expression and contents of orexin A and B in the rat brain. Neurobiol Aging. 2004;25(2):231-8.
Poyner DR. et al.
Molecular pharmacology of receptors for calcitonin-gene-related peptide, amylin and adrenomedullin. Biochem Soc Trans 1997;25(3): 1032-1036.
Quillan J. et al.
Combinatorial diffusion assay used to identify topically active MSH receptor antagonists. PNAS USA1995;92: 2894.
Rademaker MT, Cameron VA, Charles CJ, Lainchbury JG, Nicholls MG, Richards AM.
Adrenomedullin and heart failure. Regul Pept. 2003;112(1-3):51-60.
Richmond CA.
The role of arginine vasopressin in thermoregulation during fever. J Neurosci Nurs. 2003;35(5):281-6.
Rijkers DT, Kruijtzer JA, Van Oostenbrugge M, Ronken E, Den Hartog JA, Liskamp RM. Structure-Activity Studies on the Corticotropin Releasing Factor Antagonist Astressin, leading to a Minimal Sequence necessary for Antagonistic Activity.
Chembiochem. 2004;5(3):340-348.
Rodriguez Ayala E, Pecoits-Filho R, Heimburger O, Lindholm B, Nordfors L, Stenvinkel P. Associations between plasma ghrelin levels and body composition in end-stage renal disease: a longitudinal study.
Nephrol Dial Transplant. 2004;19(2):421-6.
Roesler R, Lessa D, Venturella R, Vianna MR, Luft T, Henriques JA et al. Bombesin/gastrin-releasing peptide receptors in the basolateral amygdala regulate memory consolidation.
Eur J Neurosci. 2004;19(4):1041-1045.
Rokkaku K, Onaka T, Okada N, Ideno J, Kawakami A, Honda K, Yada T, Ishibashi S.
Neuromedin U facilitates oxytocin release from the pituitary via beta adrenoceptors. Neuroreport. 2003;14(15):1997-2000.
Rowe WB. et al.
Central administration of the neurotensin receptor antagonist, SR48892, modulates diurnal and stress- related hypothalamic-pituitary-adrenal activity.
Neuroendocrinol 1997;66(2):75-85).
Sabatier N, Caquineau C, Dayanithi G, Bull P, Douglas AJ, Guan XM et al.
Alpha-melanocyte-stimulating hormone stimulates oxytocin release from the dendrites of hypothalamic neurons while inhibiting oxytocin release from their terminals in the neurohypophysis.
J Neurosci. 2003;23(32):10351-10358.
Saito D, Hasegawa Y, Urano A.
Gonadotropin-releasing hormones modulate electrical activity of vasotocin and isotocin neurons in the brain of rainbow trout.
Neurosci Lett. 2003;351(2):107-110.
Sakamoto F, Yamada S, Ueta Y.
Centrally administered orexin-A activates corticotropin-releasing factor-containing neurons in the hypothalamic paraventricular nucleus and central amygdaloid nucleus of rats: possible involvement of central orexins on stress-activated central CRF neurons.
Regul Pept. 2004;118(3):183-91.
Sakoori K, Murphy NP.
Central administration of nociceptin/orphanin FQ blocks the acquisition of conditioned place preference to morphine and cocaine, but not conditioned place aversion to naloxone in mice.
Psychopharmacology (Berl). 2004;172(2):129-136.
Samson WK.ea.
Proadrenomedullin N-terminal - 20 peptide inhibits adrenocorticotropin secretion from cultured pituitary cells, possibly via activation of a potassium channel.
Endocrine 1998;9(3):269-272
Sanchez E. et al.
Expression of the proprotein convertases PC1 and PC2 mRNAs in TRH neurons of the rat paraventricular nucleus of hypothalamus.
Brain Res 1997;761(1):77-86.
Sandin J, Ogren SO, Terenius L.
Nociceptin/orphanin FQ modulates spatial learning via ORL-1 receptors in the dorsal hippocampus of the rat.
Brain Res. 2004;997(2):222-33.
Sarkar S, Fekete C, Legradi G, Lechan RM.
Glucagon like peptide-1 (7-36) amide (GLP-1) nerve terminals densely innervate corticotropin-releasing hormone neurons in the hypothalamic paraventricular nucleus.
Brain Res. 2003;985(2):163-168.
Schelman WR, Kurth JL, Berdeaux RL, Norby SW, Weyhenmeyer JA.
Angiotensin II type-2 (AT(2)) receptor-mediated inhibition of NMDA receptor signalling in neuronal cells. Mol Brain Res 1997;48:197-205.
Schioth HB, Lagerstrom MC, Watanobe H, Jonsson L, Vergoni AV, Ringholm A, ea
Functional role, structure, and evolution of the melanocortin-4 receptor. Ann N Y Acad Sci. 2003;994:74-83.
Schomburg L. & Bauer K.
Regulation of the adenohypophyseal thyrotropin-releasing hormone-degrading ectoenzyme by estradiol. Endocrinology 1997;138(9):3587-3593.
Scordalakes EM, Rissman EF.
Aggression and arginine vasopressin immunoreactivity regulation by androgen receptor and estrogen receptor alpha.
Genes Brain Behav. 2004;3(1):20-26.
Shadrina MI, Dolotov OV, Grivennikov IA, Slominsky PA, Andreeva LA, Inozemtseva LS, Limborska SA, Myasoedov NF.
Rapid induction of neurotro-phin mRNAs in rat glial cell cultures by Semax, an adrenocor-ticotropic hormone analog.
Neurosci Lett 2001;308(2):115-118.
Shioda S. et al.
Pituitary adenylate cyclase-activating polypeptide: a novel regulator of vasopressin-containing neurons Brain Res 1997;765(1):81-90.
Siemion IZ, Kluczyk A.
Tuftsin: on the 30-year anniversary of Victor Najjar's discovery. Peptides 1999;20(5):645-674.
Sirotkin AV, Florkovicova I, Makarevich AV, Schaeffer HJ, Kotwica J, Marnet PG, Sanislo P.
Oxytocin mediates some effects of insulin-like growth factor-I on porcine ovarian follicles. J Reprod Dev. 2003;49(2):141-149.
Smith D. et al.
Dose-dependent pain-facilitatory and -inhibitory actions of neurotensin are revealed by SR 48692, a nonpeptide neurotensin antagonist: Influence on the antinociceptive effect of morphine.
Pharmacol ExpTher 1997;282(2):899-908.
Soriano-Guillen L, Barrios V, Campos-Barros A, Argente J.
Ghrelin levels in obesity and anorexia nervosa: effect of weight reduction or recuperation. J Pediatr. 2004;144(1):36-42.
Stenfors C. et al.
Characterization of endogenous neuropeptide Y in rat hippocampus and its metabolism by nanospray mass spectrometry.
J Biol Chem 1997;272(9):5747-5751.
Tabuchi A. et al.
Involvement of endogenous PACAP expression in the activity-dependent survival of cerebellar granule cells.
Neurosci Res 2001;39(1):85-93.
Tachibana T, Hirofuji K, Matsumoto M, Furuse M, Hasegawa S, Yoshizawa F, Sugahara K.
The hypothalamus is involved in the anorexic effect of glucagon-like peptide-1 in chicks. Comp Biochem Physiol A Mol Integr Physiol. 2004;137(1):183-188.
Takei Y, Inoue K, Ogoshi M, Kawahara T, Bannai H, Miyano S.
Identification of novel adrenomedullin in mammals: a potent cardiovascular and renal regulator. FEBS Lett. 2004;556(1-3):53-8.
Tanaka K, Suzuki M, Sumiyoshi T, Murata M, Tsunoda M, Kurachi M.
Subchronic phencyclidine administration alters central vasopressin receptor binding and social interaction in the rat.
Brain Res. 2003;992(2):239-245.
Terrado J. et al.
Expression of the genes for α-type and β-type CGRP during postnatal rat brain development. Neurosci 1997;80(3): 951-970.
Thompson R, Gupta S, Miller K, Mills S, Orr S.
The effects of vasopressin on human facial responses related to social communication. Psychoneuroendocrinology. 2004;29(1):35-48.
Todd JF et al.
Galanin is a paracrine inhibitor of gonadotroph function in female rat. Endocrinology 1998;39:4222-4229.
Trollmann R, Schoof E, Beinder E, Wenzel D, Rascher W, Dotsch J.
Adrenomedullin gene expression in human placental tIssue and leukocytes: a potential marker of severe tIssue hypoxia in neonates with birth asphyxia.
Eur J Endocrinol. 2002;147(5):711-6.
Turquier V, Yon L, Grumolato L, Alexandre D, Fournier A, Vaudry H, Anouar Y.
Pituitary adenylate cyclase--activating polypeptide stimulates secretoneurin release and secretogranin II gene transcription in bovine adrenochromaffin cells.
Ann N Y Acad Sci. 2002;971:471-3.
Ukai M. et al.
Effects of plus-maze learning and spontaneous alternation performance in mice. Gen Pharmacol 1997;29(3):453-456).
Ukkola O.
Endocrinological activities of ghrelin: new insights. Eur J Intern Med. 2003;14(6):351-356.
Vallieres L. et al.
Influence of IL-6 on neural activity and transcription of the gene encoding CRF in the rat brain. Eur J Neurosci 1997;9(7):1461-1472.
Vesely et al.
Atrial natriuretic hormones originating from the N-terminus of the atrial natriurertic factor prohormone. Clin Exper Pharm Physiol 1995;22:108.
Virley D, Hadingham SJ, Roberts JC, Farnfield B, Elliott H, et al.
A new primate model of focal stroke: endothelin-1-induced middle cerebral artery occlusion and reperfusion in the common marmoset.
J Cereb Blood Flow Metab. 2004 Jan;24(1):24-41.
Watanabe T, Saiki Y, Sakata Y.
The effect of central angiotensin II receptor blockade on interleukin-1 beta-and prostaglandin E-induced fevers in rats: Possible involvement of brain angiotensin II receptor in fever induction.
J Pharmacol Exp Ther 1997;282(2):873-881.
Wei Y, Ouyang D, Liu Y, Chang Z, Tang J, Ding J.
Peripheral tissue distribution of orphanin FQ precusor mRNA in stroke-prone spontaneously hypertensive rats. Chin Med Sci J. 1999;14(2):67-70.
Wierup N, Kuhar M, Nilsson BO, Mulder H, Ekblad E, Sundler F.
Cocaine- and amphetamine-regulated transcript (CART) is expressed in several islet cell types during rat development.
J Histochem Cytochem. 2004;52(2):169-77.
Wijdicks E.
Increase and uncoupling of adrenomedullin from the natriuretic peptide system in aneurysmal subarachnoid hemorrhage.
J Neurosurg 2001;94(2):252-256.
Winnicka MM, Braszko JJ.
6- OHDA lesions to the central amygdala abolish angiotensins facilitation of object recognition in rats. Gen Pharmacol 1997;29(2):239-243.
Wisse BE, Schwartz MW, Cummings DE.
Melanocortin signaling and anorexia in chronic disease states. Ann N Y Acad Sci. 2003;994:275-281.
Witta J, Buzas B, Cox BM.
Traumatic brain injury induces nociceptin/orphanin FQ expression in neurons of the rat cerebral cortex. J Neurotrauma. 2003;20(6):523-532.
YamadaK. et al.
Neuropeptide Y reverses corticotropin releasing hormone and psychological stress caused shortening of sodium penrabarbital-induced sleep in rats.
Brain Res 1996; 725(2): 272-275.
Yamaguchi Y. & Kobayashi H.
Effects of vasoactive intestinal peptide (VIP) on scopolamine-induced amnesia in the rat. Neuropeptides 1994;26(3):153-158.
Yamamoto H, Lee CE, Marcus JN, Williams TD, Overton JM, Lopez ME, et al.
Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons.
J Clin Invest. 2002;110(1):43-52.
Yang H, Lu D, Raizada MK.
Angiotensin II-induced phosphorylation of the AT(1) receptor from brain neurons. Hypertens 1997;30(Part 1):351-357.
Young WS 3rd, Gainer H.
Transgenesis and the study of expression, cellular targeting and function of oxytocin, vasopressin and their receptors.
Neuroendocrinology. 2003;78(4):185-203.
Zhang JH. et al.
Orexin (Hypocretin) –like immunoreactivity in cat hypothalamus: a light and electron microscopic study Sleep 2001;24(1): 67-76.
Zhao X. et al.
Corticotropin-releasing hormone-binding protein and its possible role in neuroendo-crinological research. Horm Metab Res 1997;29(8):373-378.
====================================
Еще по теме ЛИТЕРАТУРА К РАЗДЕЛУ II:
- ЛИТЕРАТУРА
- ЛИТЕРАТУРА
- Раздел Vl МИКРОСКОПИЧЕСКАЯ ТЕХНИКА
- ЛИТЕРАТУРА
- Литература
- Литература
- Литература
- Литература
- Дополнительная литература
- Дополнительная литература
- РЕКОМЕНДУЕМАЯ ЛИТЕРАТУРА
- Литература
- СПИСОК ЛИТЕРАТУРЫ
- Литература
- ЛИТЕРАТУРА
- Список рекомендуемой литературы и веб-сайты
- РАЗДЕЛ III. ПЕПТИДЫ И РОСТОВЫЕ НЕЙРОТРОФИЧЕСКИЕ ФАКТОРЫ: РЕГУЛЯЦИЯ ФИЗИОЛОГИЧЕСКИХ И ПАТОФИЗИОЛОГИЧЕСКИХ ПРОЦЕССОВ